Mucosal Immunization with a Novel Nanoemulsion-Based Recombinant Anthrax Protective Antigen Vaccine Protects against Bacillus anthracis Spore Challenge

The currently available commercial human anthrax vaccine requires multiple injections for efficacy and has side effects due to its alum adjuvant. These factors limit its utility when immunizing exposed populations in emergent situations. We evaluated a novel mucosal adjuvant that consists of a nonto...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Bielinska, Anna U., Janczak, Katarzyna W., Landers, Jeffrey J., Makidon, Paul, Sower, Laurie E., Peterson, Johnny W., Baker, James R.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2007
Assuntos:
Microbial Immunity and Vaccines
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1952013/
https://ncbi.nlm.nih.gov/pubmed/17502384
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/IAI.00070-07
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados